CA1040532A - Process for producing solid bismuth-containing pharmaceutical compositions - Google Patents

Process for producing solid bismuth-containing pharmaceutical compositions

Info

Publication number
CA1040532A
CA1040532A CA218,092A CA218092A CA1040532A CA 1040532 A CA1040532 A CA 1040532A CA 218092 A CA218092 A CA 218092A CA 1040532 A CA1040532 A CA 1040532A
Authority
CA
Canada
Prior art keywords
dry powder
bismuth
pharmaceutical composition
bi2o3
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA218,092A
Other languages
English (en)
French (fr)
Other versions
CA218092S (en
Inventor
Christopher J. Mcloughlin
Ross B. Himstedt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gist Brocades NV
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Application granted granted Critical
Publication of CA1040532A publication Critical patent/CA1040532A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA218,092A 1974-01-18 1975-01-17 Process for producing solid bismuth-containing pharmaceutical compositions Expired CA1040532A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA00740385A ZA74385B (en) 1974-01-18 1974-01-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CA1040532A true CA1040532A (en) 1978-10-17

Family

ID=25567281

Family Applications (1)

Application Number Title Priority Date Filing Date
CA218,092A Expired CA1040532A (en) 1974-01-18 1975-01-17 Process for producing solid bismuth-containing pharmaceutical compositions

Country Status (18)

Country Link
JP (1) JPS5837284B2 (zh)
AT (1) AT349150B (zh)
AU (1) AU485660B2 (zh)
BE (1) BE824509A (zh)
CA (1) CA1040532A (zh)
CH (1) CH622947A5 (zh)
DE (1) DE2501787A1 (zh)
DK (1) DK151770C (zh)
ES (1) ES433908A1 (zh)
FI (1) FI750113A (zh)
FR (1) FR2258177B1 (zh)
GB (1) GB1478742A (zh)
IE (1) IE40361B1 (zh)
IT (1) IT1036072B (zh)
LU (1) LU71668A1 (zh)
NL (1) NL185130C (zh)
SE (1) SE437930B (zh)
ZA (1) ZA74385B (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
US4801608A (en) * 1981-09-22 1989-01-31 Gist-Brocades N. V. Bismuth containing composition and method for the preparation thereof
WO1986005981A1 (en) * 1985-04-18 1986-10-23 Borody Thomas J Treatment of non-ulcer dyspepsia with bismuth salts
US4748113A (en) * 1985-06-13 1988-05-31 Marshall Barry J Compositions and methods for the diagnosis of gastrointestinal disorders involving urease
EP0707854B1 (en) * 1985-06-13 2006-02-22 Barry James Dr. Marshall Compositions for the treatment of gastronitestinal disorders containing bismuth and an antimicrobial
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
ATE79261T1 (de) * 1985-06-13 1992-08-15 Barry James M D Marshall Verfahren zur behandlung von magen-darmstoerungen.
DE3865201D1 (de) * 1988-10-08 1991-10-31 Pfleger R Chem Fab Fluessiges, wismuthaltiges arzneipraeparat, verfahren zum herstellen desselben und seine verwendung.
DE3901508C2 (de) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
IT1229502B (it) * 1989-01-25 1991-09-03 Euroresearch Srl Composizioni contenenti bismuto idonee per uso terapeutico.
IE893167A1 (en) * 1989-10-04 1991-04-24 Ulso Lab Ltd Preparation of orally administrable liquids for use in¹therapy
IE65964B1 (en) * 1990-07-20 1996-01-24 Slagel David Products and processes for the treatment of the alimentary canal
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
MX9703918A (es) 1997-05-28 1998-11-30 J Marshall M D Barry Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
US6998250B2 (en) 2001-10-15 2006-02-14 Donald J. McMichael Method for detecting Helicobacter pylori
US7008777B2 (en) 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
USD484988S1 (en) 2001-12-17 2004-01-06 Kimberly-Clark Worldwide, Inc. Diagnostic test kit with specimen-handling tool
US6783976B2 (en) 2001-12-21 2004-08-31 Kimberly-Clark Worldwide, Inc. Carrier and specimen-handling tool for use in diagnostic testing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1259151A (en) * 1968-12-23 1972-01-05 Willem Jacob Serfontein Bismuth complexes
DE1963781A1 (de) * 1968-12-23 1970-07-09 Serfontein Willem Jacob Verbesserte Wismuth-Praeparate

Also Published As

Publication number Publication date
SE7500501L (zh) 1975-07-21
DK12675A (zh) 1975-09-15
AU7729375A (en) 1976-07-15
JPS5837284B2 (ja) 1983-08-15
FR2258177B1 (zh) 1978-07-21
ES433908A1 (es) 1976-11-16
SE437930B (sv) 1985-03-25
DK151770B (da) 1988-01-04
AU485660B2 (en) 1977-07-28
ZA74385B (en) 1975-08-27
IT1036072B (it) 1979-10-30
JPS50116623A (zh) 1975-09-12
FI750113A (zh) 1975-07-19
DE2501787C2 (zh) 1987-11-12
GB1478742A (en) 1977-07-06
NL7500552A (nl) 1975-07-22
CH622947A5 (en) 1981-05-15
ATA31875A (de) 1978-08-15
IE40361B1 (en) 1979-05-09
LU71668A1 (zh) 1975-06-24
FR2258177A1 (zh) 1975-08-18
IE40361L (en) 1975-07-18
DE2501787A1 (de) 1975-07-24
DK151770C (da) 1989-11-06
NL185130C (nl) 1990-02-01
AT349150B (de) 1979-03-26
NL185130B (nl) 1989-09-01
BE824509A (fr) 1975-07-17

Similar Documents

Publication Publication Date Title
CA1040532A (en) Process for producing solid bismuth-containing pharmaceutical compositions
US4956386A (en) Pharmaceutical compositions and process for their preparation
US5019563A (en) Pharmaceutical composition
CA1254143A (en) Pharmaceutical preparation with a content of ibuprofen, and process for its preparation
US3898328A (en) Dry stable composition for the treatment of scours and dehydration
EP0011489B1 (en) An analgesic effervescent powder and process for its preparation
JPS60208979A (ja) シクロデキストリンとの複合化包接化合物、その製造方法および該化合物を含有する抗炎症、鎮痛および解熱効果を有する医薬組成物
EP0524579B1 (en) Improved oral dosing formulations of dideoxy purine nucleosides
US4801608A (en) Bismuth containing composition and method for the preparation thereof
FI77156C (fi) Foerfarande foer framstaellning av en fast vismuthaltig komposition.
Hillyard et al. Antacid and antiulcer properties of the polysaccharide chitosan in the rat
SU1009467A1 (ru) Средство дл растворени мочевых конкрементов
US3928609A (en) Non-alcoholic theophylline product
JPH09502709A (ja) エストロン誘導体及びカルシウム塩含有の経口、水溶性製薬組成物
US2883327A (en) Reducing the gelation of methylcellulose by the addition of a neutral, water-soluble, amino carboxylic acid and product thereof
RU2589507C1 (ru) Средство на основе сухого экстракта пустырника и способ его получения
GB2061111A (en) Long acting pharmaceutical composition
US3655883A (en) Water soluble magnesium-aluminum antacid composition
JPH0222225A (ja) 胃酸分泌抑制剤含有固型製剤
JP2000080034A (ja) 風邪用組成物
JPH03287531A (ja) 膵炎治療薬
JPS58116423A (ja) メタノプロスタサイクリン製剤組成物
JPH0322874B2 (zh)
JPS6357520A (ja) 抗漬瘍剤
Stone Pharmaceutical application of ferrous gluconate NF